Extrait

This is a Phase III trial designed to demonstrate that casopitant when added to dexamethasone and ondansetron is more effective in the prevention of vomiting then dexamethasone and ondansetron alone, in patients who receive a cisplatin-based highly emetogenic chemotherapy.

Critère d'inclusion

• Nausea ,Vomiting

Pays

• Argentina
• Belgium
• Bulgaria
• Croatia
• Czech Republic
• Finland
• Greece
• Hungary
• India
• Ireland
• Italy
• Korea, Republic of
• Malaysia
• Pakistan
• Philippines
• Poland
• Romania
• Slovakia
• Spain
• Taiwan, Province of China
• Thailand
• Ukraine

Liens

• nct
• ictrp